Search Results 1451-1460 of 16407 for sjogren

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. A Study to Explore Clinicians’ Point-Of-Care Decision-Making Process and Behavior following a Pharmacogenomics Alert - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Patient Stories - Jeremy T. Larsen, M.D. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  7. Membership - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Faculty members conducting research in the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.

  8. LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) - Mayo Clinic

    The purpose of this study is to provide the lung volume reduction coil treatment procedure to patients who were randomized to the control group in study CLN0009 ...

  9. Complex regional pain syndrome - Doctors and departments - Mayo Clinic

    Learn about this neurological condition that may affect an arm or a leg after an injury or surgery. Early treatment may prevent a recurrence.

  10. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...